{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:24:15Z","timestamp":1790976255451,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7232260"],"award-info":[{"award-number":["7232260"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L246065"],"award-info":[{"award-number":["L246065"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204369"],"award-info":[{"award-number":["82204369"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bcp.2025.117617","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:00:50Z","timestamp":1765036850000},"page":"117617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Inhibition of CXCR2 improves motor coordination through attenuating white matter lesions in Parkinson\u2019s disease models"],"prefix":"10.1016","volume":"244","author":[{"given":"Yueqi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meichuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoupeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senxiang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10423","key":"10.1016\/j.bcp.2025.117617_b0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"issue":"10423","key":"10.1016\/j.bcp.2025.117617_b0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","article-title":"Medical, surgical, and physical treatments for Parkinson's disease","volume":"403","author":"Foltynie","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2025.117617_b0015","doi-asserted-by":"crossref","unstructured":"C. Owens-Walton, T.M. Nir, S. Al-Bachari, S. Ambrogi, T.J. Anderson, \u00cd.K. Aventurato, F. Cendes, Y.-L. Chen, V. Ciullo, P. Cook, J.C. Dalrymple-Alford, M.F. Dirkx, J. Druzgal, H.C.A. Emsley, R. Guimar\u00e3es, H.A. Haroon, R.C. Helmich, M.T. Hu, M.E. Johansson, H.B. Kim, J.C. Klein, M. Laansma, K.E. Lawrence, C. Lochner, C. Mackay, C.T. McMillan, T.R. Melzer, L. Nabulsi, B. Newman, P. Opriessnig, L.M. Parkes, C. Pellicano, F. Piras, F. Piras, L. Pirpamer, T.L. Pitcher, K.L. Poston, A. Roos, L.S. Silva, R. Schmidt, P. Schwingenschuh, M. Shahid-Besanti, G. Spalletta, D.J. Stein, S.I. Thomopoulos, D. Tosun, C.-C. Tsai, O.A. van den Heuvel, E. van Heese, D. Vecchio, J.E. Villal\u00f3n-Reina, C. Vriend, J.-J. Wang, Y.-R. Wu, C.L. Yasuda, P.M. Thompson, N. Jahanshad, Y. van der Werf, A worldwide study of white matter microstructural alterations in people living with Parkinson\u2019s disease, npj Parkinson's Disease 10(1) (2024) 151.","DOI":"10.1038\/s41531-024-00758-3"},{"issue":"6","key":"10.1016\/j.bcp.2025.117617_b0020","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/mds.29804","article-title":"White matter microstructural underpinnings of mild behavioral impairment in Parkinson's disease","volume":"39","author":"Monchi","year":"2024","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.bcp.2025.117617_b0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00401-025-02884-5","article-title":"Oligodendroglia vulnerability in the human dorsal striatum in Parkinson\u2019s disease","volume":"149","author":"Barba-Reyes","year":"2025","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117617_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115266","article-title":"Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson's disease via the prosaposin-GPR37-IL-6 axis","volume":"44","author":"Ma","year":"2025","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.bcp.2025.117617_b0035","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41583-023-00711-y","article-title":"Mechanisms of axonal support by oligodendrocyte-derived extracellular vesicles","volume":"24","author":"Kr\u00e4mer-Albers","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117617_b0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/dna.2019.5182","article-title":"CXCR2 signaling and remyelination in preclinical models of demyelination","volume":"39","author":"Skinner","year":"2019","journal-title":"DNA Cell Biol."},{"issue":"18","key":"10.1016\/j.bcp.2025.117617_b0045","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00240-19","article-title":"Disrupted CXCR2 signaling in oligodendroglia lineage cells enhances myelin repair in a viral model of multiple sclerosis","volume":"93","author":"Marro","year":"2019","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117617_b0050","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1212\/NXI.0000000000000174","article-title":"Spatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells: role in myelin repair","volume":"2","author":"Liu","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"27","key":"10.1016\/j.bcp.2025.117617_b0055","doi-asserted-by":"crossref","first-page":"9074","DOI":"10.1523\/JNEUROSCI.1238-10.2010","article-title":"Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells","volume":"30","author":"Liu","year":"2010","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.bcp.2025.117617_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011340","article-title":"CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination","volume":"5","author":"Hosking","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117617_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.105988","article-title":"Inhibition of CXCR2 enhances CNS remyelination via modulating PDE10A\/cAMP signaling pathway","volume":"177","author":"Ju","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2025.117617_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104630","article-title":"CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis","volume":"134","author":"Wang","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2025.117617_b0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fnins.2020.00045","article-title":"src inhibition attenuates neuroinflammation and protects dopaminergic neurons in Parkinson's disease models","volume":"14","author":"Yang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bcp.2025.117617_b0080","article-title":"FLZ attenuates Parkinson's disease pathological damage by increasing glycoursodeoxycholic acid production via down-regulating Clostridium innocuum","author":"Shang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.bcp.2025.117617_b0085","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1039\/D1FO02127C","article-title":"Gardenia jasminoides J. ellis extract alleviated white matter damage through promoting the differentiation of oligodendrocyte precursor cells via suppressing neuroinflammation","volume":"13","author":"Zang","year":"2022","journal-title":"Food Function"},{"issue":"1","key":"10.1016\/j.bcp.2025.117617_b0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-023-01312-y","article-title":"The toxic natural product tutin causes epileptic seizures in mice by activating calcineurin","volume":"8","author":"Han","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"19","key":"10.1016\/j.bcp.2025.117617_b0095","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1021\/acs.jmedchem.6b00976","article-title":"A novel Parkinson's disease drug candidate with potent anti-neuroinflammatory effects through the Src signaling pathway","volume":"59","author":"Wang","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117617_b0100","article-title":"Whole body vibration improves spatial memory anxiety-like behavior, and motor performance in aged male and female rats","volume":"13","author":"Oroszi","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bcp.2025.117617_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104538","article-title":"Caffeic acid reduces A53T \u03b1-synuclein by activating JNK\/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease","volume":"150","author":"Zhang","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117617_b0110","article-title":"GJ-4 alleviates A\u03b2(25-35)-induced memory dysfunction in mice through protecting the neurovascular unit","volume":"127","author":"Zhang","year":"2020","journal-title":"Biomed. Pharmaco. Biomed. Pharmaco."},{"issue":"6","key":"10.1016\/j.bcp.2025.117617_b0115","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/mds.28510","article-title":"White matter hyperintensities, dopamine loss, and motor deficits in de novo Parkinson's disease","volume":"36","author":"Jeong","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bcp.2025.117617_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117518","article-title":"Clinical correlates of white matter lesions in Parkinson's disease using automated multi-modal segmentation measures","volume":"427","author":"Fang","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117617_b0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40708-023-00215-6","article-title":"The onset of motor learning impairments in Parkinson\u2019s disease: a computational investigation","volume":"11","author":"Gigi","year":"2024","journal-title":"Brain Inf."},{"issue":"3","key":"10.1016\/j.bcp.2025.117617_b0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neubiorev.2006.09.008","article-title":"Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development","volume":"31","author":"Janhunen","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2025.117617_b0135","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.neuron.2017.01.019","article-title":"Parkinson sac domain mutation in synaptojanin 1 impairs clathrin uncoating at synapses and triggers dystrophic changes in dopaminergic axons","volume":"93","author":"Cao","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2025.117617_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105326","article-title":"Asparagine endopeptidase cleaves synaptojanin 1 and triggers synaptic dysfunction in Parkinson's disease","volume":"154","author":"Zou","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117617_b0145","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11357-024-01428-1","article-title":"White matter lesions contribute to motor and non-motor disorders in Parkinson's disease: a critical review","volume":"47","author":"Jiang","year":"2025","journal-title":"Geroscience"},{"issue":"4","key":"10.1016\/j.bcp.2025.117617_b0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jamaneurol.2013.6233","article-title":"Parkinson disease subtypes","volume":"71","author":"Thenganatt","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bcp.2025.117617_b0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neurobiolaging.2019.05.004","article-title":"Age- and disease-related cerebral white matter changes in patients with Parkinson's disease","volume":"80","author":"de Schipper","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bcp.2025.117617_b0160","article-title":"A longitudinal fixel-based analysis of white matter alterations in patients with Parkinson's disease","volume":"24","author":"Rau","year":"2019","journal-title":"NeuroImage: Clinical"},{"issue":"9","key":"10.1016\/j.bcp.2025.117617_b0165","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1007\/s00415-020-09863-8","article-title":"Progression of grey and white matter brain damage in Parkinson's disease: a critical review of structural MRI literature","volume":"268","author":"Sarasso","year":"2021","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117617_b0170","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1212\/WNL.0000000000009890","article-title":"Areas of white matter hyperintensities and motor symptoms of Parkinson disease","volume":"95","author":"Lee","year":"2020","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.bcp.2025.117617_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107266","article-title":"CXCR2 antagonism attenuates neuroinflammation after subarachnoid hemorrhage","volume":"32","author":"Luo","year":"2023","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.bcp.2025.117617_b0180","article-title":"Programmed cell death 10 mediated CXCL2-CXCR2 signaling in regulating tumor-associated microglia\/macrophages recruitment in glioblastoma","volume":"12\u20132021","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2025.117617_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2012.02.016","article-title":"Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?","volume":"246","author":"Veenstra","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117617_b0190","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/glia.21195","article-title":"CXCR2 signaling protects oligodendrocyte progenitor cells from IFN-\u03b3\/CXCL10-mediated apoptosis","volume":"59","author":"Tirotta","year":"2011","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.bcp.2025.117617_b0195","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nn.2491","article-title":"CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis","volume":"13","author":"Liu","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bcp.2025.117617_b0200","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.molimm.2018.08.002","article-title":"Interleukin 8 (CXCL8)-CXC chemokine receptor 2 (CXCR2) axis contributes to MiR-4437-associated recruitment of granulocytes and natural killer cells in ischemic stroke","volume":"101","author":"He","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bcp.2025.117617_b0205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12974-015-0339-z","article-title":"Pharmacological antagonism of interleukin-8 receptor CXCR2 inhibits inflammatory reactivity and is neuroprotective in an animal model of Alzheimer's disease","volume":"12","author":"Ryu","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bcp.2025.117617_b0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","article-title":"Peripheral cytokines profile in Parkinson\u2019s disease","volume":"23","author":"Reale","year":"2009","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117617_b0215","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmed.2023.09.003","article-title":"CXCR2 chemokine receptor - a master regulator in cancer and physiology","volume":"30","author":"Lazennec","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bcp.2025.117617_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110330","article-title":"The role of CXCL1\/CXCR2 axis in neurological diseases","volume":"120","author":"Jiang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117617_b0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.24272\/j.issn.2095-8137.2024.228","article-title":"Elevated CXCL1 triggers dopaminergic neuronal loss in the substantia nigra of C57BL\/6J mice: evaluation of a novel Parkinsonian mouse model","volume":"46","author":"Ma","year":"2025","journal-title":"Zool. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117617_b0230","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41401-023-01147-x","article-title":"Gut microbiota-induced CXCL1 elevation triggers early neuroinflammation in the substantia nigra of Parkinsonian mice","volume":"45","author":"Ma","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bcp.2025.117617_b0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12974-020-1730-y","article-title":"Neutrophil-selective deletion of Cxcr2 protects against CNS neurodegeneration in a mouse model of multiple sclerosis","volume":"17","author":"Khaw","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.bcp.2025.117617_b0240","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neures.2012.12.004","article-title":"The axon as a unique computational unit in neurons","volume":"75","author":"Sasaki","year":"2013","journal-title":"Neurosci. Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117617_b0245","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuron.2014.10.019","article-title":"Axonal transport: cargo-specific mechanisms of motility and regulation","volume":"84","author":"Maday","year":"2014","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.bcp.2025.117617_b0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000621","article-title":"Oligodendrocytes support axonal transport and maintenance via exosome secretion","volume":"18","author":"Fr\u00fchbeis","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bcp.2025.117617_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136288","article-title":"Mini-review: Synaptojanin 1 and its implications in membrane trafficking","volume":"765","author":"Choudhry","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.bcp.2025.117617_b0260","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/jnc.15974","article-title":"\u03b1-Synuclein induces deficiency in clathrin-mediated endocytosis through inhibiting synaptojanin1 expression","volume":"167","author":"Song","year":"2023","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.bcp.2025.117617_b0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41419-018-0410-7","article-title":"Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations","volume":"9","author":"Fasano","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117617_b0270","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41531-024-00769-0","article-title":"Parkinson\u2019s disease gene, Synaptojanin1, dysregulates the surface maintenance of the dopamine transporter","volume":"10","author":"Saenz","year":"2024","journal-title":"npj Parkinson's Dis."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:20:54Z","timestamp":1773872454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225008822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":54,"alternative-id":["S0006295225008822"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117617","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of CXCR2 improves motor coordination through attenuating white matter lesions in Parkinson\u2019s disease models","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117617"}}